The CCK8 assay indicated that in contrast with the sh-NC group, TRIM14 knockdown remarkably hampered the viability of HCC cells treated with cisplatin (p < 0.05, Figure 5A,B). The gene discussed is TRIM14; the disease is hepatocellular carcinoma.